Biotech · Private company · Lawrence, KS, US
Oak Therapeutics, Inc.
Track this companyFree. Adds Oak Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Novel antiretroviral therapy delivery platform for infants and young children: oral dispensable strips (ODS)Fiscal year 2026 · $899KNIH RePORTER 2R44AI170237-02A1 · fetched Nov 12, 2026
- Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosisFiscal year 2026 · $814.3KNIH RePORTER 5R44AI179391-03 · fetched Nov 12, 2026
- Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosisFiscal year 2025 · $892.8KNIH RePORTER 2R44AI179391-02 · fetched Nov 12, 2026